We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

93 hedge funds and large institutions have $244M invested in BioSpecifics Technologies Corp. in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

29% more capital invested

Capital invested by funds: $189M → $244M (+$54.3M)

21% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 28

16% more funds holding

Funds holding: 80 → 93 (+13)

Holders
93
Holders Change
+13
Holders Change %
+16.25%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
17
Increased
34
Reduced
28
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.22M
2
CCM
Cadence Capital Management
Massachusetts
+$2.52M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.31M
4
EP
Eversept Partners
New York
+$1.12M
5
EGI
EAM Global Investors
California
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$8.98M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$2.86M
3
ECP
Elk Creek Partners
Colorado
-$2.43M
4
Millennium Management
Millennium Management
New York
-$1.58M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$2.55M +$109K +2,130 +5%
TCIM
27
TIAA CREF Investment Management
New York
$2.07M -$23.6K -463 -1%
OAM
28
Oxford Asset Management
United Kingdom
$2.04M -$227K -4,442 -11%
Man Group
29
Man Group
United Kingdom
$2M +$40.8K +800 +2%
CAM
30
ClariVest Asset Management
California
$1.75M -$61.9K -1,214 -4%
Morgan Stanley
31
Morgan Stanley
New York
$1.69M +$226K +4,423 +18%
Invesco
32
Invesco
Georgia
$1.51M +$113K +2,207 +9%
MCM
33
Matarin Capital Management
New York
$1.32M +$116K +2,278 +11%
EP
34
Eversept Partners
New York
$1.28M +$1.12M +21,900 New
EGI
35
EAM Global Investors
California
$1.21M +$1.05M +20,642 New
PVI
36
Pura Vida Investments
New York
$1.18M +$1.03M +20,160 New
Two Sigma Investments
37
Two Sigma Investments
New York
$1.15M +$154K +3,011 +18%
IP
38
Isthmus Partners
Wisconsin
$1.14M +$10.4K +204 +1%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$1.13M -$340K -6,663 -26%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.06M – – –
EI
41
EAM Investors
California
$957K +$835K +16,368 New
Deutsche Bank
42
Deutsche Bank
Germany
$933K -$1.25M -24,544 -61%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$819K +$56.1K +1,100 +9%
SO
44
STRS Ohio
Ohio
$725K -$30.6K -600 -5%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$705K -$27.6K -540 -4%
PPA
46
Parametric Portfolio Associates
Washington
$670K -$26K -510 -4%
TA
47
Teachers Advisors
New York
$585K -$5.1K -100 -1%
ADEF
48
Adams Diversified Equity Fund
Maryland
$567K +$495K +9,700 New
American Century Companies
49
American Century Companies
Missouri
$531K -$52.7K -1,032 -10%
CIBC Private Wealth Group
50
CIBC Private Wealth Group
Georgia
$523K -$14.3K -280 -3%
1
2
3 4

BSTC Hedge Fund Activity: Q3 2018 in Review

93 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2018, worth a combined $244M — up 29% from $189M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BSTC positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $4.22M. The largest seller was Stonepine Capital Management, cutting an estimated $8.98M.

  • 93 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2018, up from 80 in Q2 2018.
  • Funds reported $244M of BioSpecifics Technologies Corp. stock for Q3 2018, up 29% quarter-over-quarter.
  • 17 funds opened new BioSpecifics Technologies Corp. positions in Q3 2018 and 4 closed out, a net change of +13 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2018 was BlackRock, an estimated $4.22M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2018 was Stonepine Capital Management, an estimated $8.98M sold.

Based on aggregated 13F filings for Q3 2018.